Financial Performance - Total revenue for the year ended December 31, 2025, was HKD 95,198,000, a decrease of 5.6% from HKD 100,977,000 in 2024[3] - Gross profit for 2025 was HKD 15,305,000, down 28.2% from HKD 21,319,000 in 2024[3] - The company reported a loss before tax of HKD 85,854,000, compared to a loss of HKD 80,794,000 in the previous year, indicating a 6.4% increase in losses[3] - Basic and diluted loss per share for 2025 was HKD 5.09, compared to HKD 4.79 in 2024, reflecting a 6.3% increase in loss per share[3] - The company reported a loss attributable to shareholders of HKD 85,854,000 for the year ended December 31, 2025, compared to a loss of HKD 80,813,000 in 2024[27] - The group's net loss attributable to shareholders for 2025 was HKD 85,900,000, an increase from HKD 80,800,000 in 2024, mainly due to losses from joint ventures and impairment losses on property, plant, and equipment[56] Assets and Liabilities - Non-current assets decreased to HKD 209,459,000 in 2025 from HKD 324,253,000 in 2024, a decline of 35.4%[5] - Current assets increased to HKD 92,887,000 in 2025 from HKD 68,203,000 in 2024, a rise of 36.3%[5] - Total liabilities increased to HKD 55,274,000 in 2025 from HKD 48,156,000 in 2024, an increase of 14.1%[6] - The company's total equity decreased to HKD 277,726,000 in 2025 from HKD 340,881,000 in 2024, a decline of 18.6%[6] - Total assets decreased by HKD 58,400,000 or 14.9% to HKD 334,000,000 as of December 31, 2025, primarily due to fair value losses on investment properties[59] Revenue Breakdown - Revenue from customer contracts in 2025 was HKD 90,191, down from HKD 94,757 in 2024, representing a decline of 4.8%[13] - The distribution segment generated revenue of HKD 87,454 in 2025, a slight decrease of 1.0% from HKD 88,360 in 2024[18] - The production segment's revenue dropped significantly from HKD 6,397 in 2024 to HKD 2,737 in 2025, a decline of 57.3%[18] - Rental income decreased to HKD 5,007 in 2025 from HKD 6,220 in 2024, reflecting a decline of 19.5%[18] - Revenue from the Hong Kong market in 2025 was HKD 87.5 million, accounting for approximately 91.9% of total revenue, compared to HKD 88.4 million and 87.5% in 2024[43] - Revenue from the mainland China market was approximately HKD 7.7 million in 2025, representing about 8.1% of total revenue, down from approximately HKD 12.6 million and 12.5% in 2024[43] Operational Changes and Strategies - The company plans to continue its operations in the sale of daily necessities, healthcare products, and food products in China and Hong Kong[7] - The company plans to continue focusing on the distribution and production segments while exploring new investment opportunities in the market[19] - The company plans to optimize its business segments to enhance sales and profitability while seeking to exit loss-making projects and reallocate resources to growth areas[76] - The production division is stabilizing a new production line for healthy instant noodles, which includes a focus on health-conscious ingredients, indicating a strategic shift towards health-oriented products[75] - The company is actively expanding its distribution channels for healthcare products and has established a dedicated internal team for its pet products division, indicating a diversification strategy[75] Employee and Administrative Costs - Total employee costs decreased to HKD 19,715,000 in 2025 from HKD 22,030,000 in 2024, reflecting a reduction in other employee costs and bonuses[26] - Administrative expenses decreased by 20.7% to HKD 35,400,000 in 2025 from HKD 44,700,000 in 2024, primarily due to lower employee costs[54] - The company employed approximately 43 staff members as of December 31, 2025, down from 59 in 2024, indicating a potential restructuring or efficiency drive[77] Governance and Compliance - The company has adhered to the Corporate Governance Code and all provisions of the Corporate Governance Report, with the exception of the separation of roles between the Chairman and the CEO, which is currently held by Mr. Wang[80] - The Audit Committee, composed of three independent non-executive directors, has reviewed and approved the consolidated financial statements for the year ending December 31, 2025[84] - The company did not purchase, sell, or redeem any of its listed securities during the year ending December 31, 2025[83] - The remuneration committee's scope does not include reviewing the remuneration of senior management, as the board believes that executive directors are more suitable for this task[81] - The company will timely distribute the annual report containing all information required by the Stock Exchange Listing Rules to its shareholders[86] Credit Risk and Financial Management - The expected credit loss provision was HKD 279,000, representing 6.2% of the total principal amount, compared to HKD 755,000 or 7.95% in 2024[66] - The total principal amount of loans as of December 31, 2025, was HKD 4,500,000, down from HKD 9,500,000 in 2024, indicating a significant reduction in loan exposure[65] - The probability of default (PD) for the expected credit loss assessment ranged from 2.67% to 3.05% in 2025, compared to 1.04% to 5% in 2024, reflecting an increase in credit risk[70] - The expected credit loss model is based on a weighted probability approach, considering factors such as exposure at default (EAD), loss given default (LGD), and forward-looking factors, which are crucial for assessing credit risk[67] Investment and Future Outlook - The company has entered into an agreement to sell an investment property in Shanghai for RMB 6,368,208 (approximately HKD 7.06 million), expected to be completed by July 31, 2026[38] - As of December 31, 2025, the carrying value of assets classified as held for sale was HKD 25.5 million, including equity investments and cash[41] - The company has signed a memorandum of understanding to sell its 51.39% equity interest in Beijing Hengjia, with the assets classified as held for sale as of December 31, 2025[40] - The company is focusing on expanding its lending operations in Hong Kong, primarily providing first and second mortgage financing secured by properties, with a strong emphasis on risk management[75] - The economic outlook for Hong Kong is cautiously optimistic, supported by a robust stock market and recovering investment spending, although consumer spending remains slightly down[74]

中國恒嘉融資租賃集團有限公司（「本公司」）董事會（「董事會」）宣佈將於二零二六年三月二十五 日（星期三）舉行董事會會議，旨在（其中包括）審議及批准本公司及其附屬公司截至二零二五年 十二月三十一日止年度的全年業績及派發末期股息之建議（如有）。 於本公告日期，董事會成員包括(1)執行董事：王力平先生、蕭偉斌先生、陶可先生及吳天墅先生； 及(2)獨立非執行董事：吳國生先生、胡啟騰先生、梁耀鳴先生及林藹茵女士。 承董事會命 中國恒嘉融資租賃集團有限公司 主席兼執行董事 王力平 香港，二零二六年三月六日 （於開曼群島註冊成立之有限公司） （股份代號：379） 董事會會議召開日期 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國恒嘉融資租賃集團有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00379 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 4,000,000,000 | HKD | | 0.1 HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 4,000,000,000 | HKD | | 0.1 HKD | | 400,000,000 | 本月 ...

（於開曼群島註冊成立之有限公司） （股份代號：379） 有關出售協議補充協議之補充公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 1 除補充協議明確修訂者外，出售協議的所有其他條款及條件應保持十足效力及作用。 承董事會命 中國恒嘉融資租賃集團有限公司 茲提述中國恒嘉融資租賃集團有限公司（「本公司」）日期為二零二六年二月三日（交易時段後）之 公告（「該公告」），內容有關（其中包括）有條件出售中國恒嘉資本集團有限公司之全部已發行股本 （「出售協議」）。除另有界定外，本公告所用詞彙與該公告所界定者具有相同涵義。 本公司董事會（「董事會」）謹此宣佈，於二零二六年二月九日，賣方、買方及擔保人訂立補充協議 （「補充協議」），以修訂出售協議有關代價之付款安排之若干條款，從而給予訂約方更多靈活性。 補充協議項下之兩項主要修訂如下： (I) 出售協議第4.2(a)條（訂金付款）（即訂金人民幣7,000,000元（或其等值港元）將由買方於簽訂 出售協議後5個營業日 ...

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Implications - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction aimed at resolving disputes related to Hong Kong Hengjia [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% equity in Beijing Hengjia, which has faced operational losses due to stricter regulatory frameworks and challenging market conditions [1]. - The company lost actual control over Beijing Hengjia since August 2023 due to disputes with its Chinese joint venture partner, leading to operational deadlock and ongoing litigation [1]. Group 2: Litigation and Strategic Exit - The board has considered various solutions, including potential judicial liquidation, which could take years and incur substantial legal costs without guaranteed compensation [2]. - The ongoing litigation from Beijing Hengjia demands the company to cover approximately $20 million in unpaid capital contributions, making the sale a strategic exit to eliminate uncertainties related to the lawsuit [2]. - The sale allows the company to focus on its core business lines and utilize the proceeds to expand its loan financing and securities investment operations in Hong Kong, as well as enhance its distribution of healthcare, pet products, and health food manufacturing [2].

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Details - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction valued at RMB 70 million [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% of Beijing Hengjia's equity, classified as equity investments measured at fair value through other comprehensive income [1]. Group 2: Operational Challenges and Litigation - The subsidiary has faced operational losses in recent years due to stricter regulatory frameworks and challenging market conditions in China [1]. - Since August 2023, the company lost actual control over Beijing Hengjia due to disputes with its Chinese joint venture partner, leading to operational stagnation and ongoing litigation [1]. Group 3: Strategic Implications of the Sale - The board has considered various solutions, including potential judicial liquidation, but found them uncertain and costly, prompting the decision to proceed with the sale as a means to eliminate litigation-related uncertainties [2]. - The sale provides an immediate exit opportunity to divest non-core underperforming assets and allows the company to focus on more promising and manageable business lines [2]. - Proceeds from the sale are intended to be used to expand the company's loan financing and securities investment business in Hong Kong, as well as to enhance operations in healthcare, pet products distribution, and health food manufacturing and sales [2].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立之有限公司） （股份代號：379） 有關出售出售公司之主要交易 出售事項 茲提述本公司日期為二零二四年九月十三日、二零二四年十二月二十日、二零二五年三月十四 日及二零二五年十二月三十一日之公告（統稱「前期公告」），有關北京恒嘉與本公司全資附屬公 司香港恆嘉資本有限公司（「香港恆嘉」）之訴訟及司法解散程序。除另有界定外，本公告所用詞 彙與前期公告所載者具有相同涵義。 於二零二六年二月三日（聯交所交易時段後），作為爭議各方解決香港恆嘉爭議之安排，賣方、 買方及擔保人訂立出售協議，據此，賣方有條件同意出售而買方有條件同意購買待售股份，代 價為人民幣70,000,000元。為確保妥為及依時履行出售協議項下之買方義務，擔保人同意成為出 售協議項下之擔保人，且擔保人亦於出售協議簽訂後簽訂保證契據。完成須待（其中包括）股東 於股東特別大會上批准出售協議及其項下擬進行之交易後方可作實。 出售公司（本 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國恒嘉融資租賃集團有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00379 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 4,000,000,000 | HKD | | 0.1 HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 4,000,000,000 | HKD | | 0.1 HKD | | 400,000,000 | 本月 ...

Core Viewpoint - Dongtong Tui (300379) has completed its last trading day on January 21, 2026, and announced its delisting. However, during the 15-day delisting adjustment period, there has been significant capital accumulation, raising questions about potential control disputes and coordinated actions among investors [1]. Group 1: Trading Activity - Guotai Haitong Securities Fuyang Xihu Avenue branch has been aggressively buying Dongtong Tui shares for 14 consecutive trading days, accumulating a total purchase amount of 86.12 million yuan, with only 875 yuan in sales [1][3]. - The estimated shareholding from this branch reached 51.28 million shares, accounting for 9.19% of the total share capital, surpassing the 5% disclosure threshold and the controlling shareholder Huang Yongjun's 7.66% stake [1][3]. - The buying activity has been characterized by a steady increase in daily purchase amounts, peaking at 9.49 million yuan on January 19, 2026 [3]. Group 2: Institutional Participation - Multiple institutional seats have appeared on the trading leaderboard, with significant net purchases, including 7.89 million yuan on January 21, 2026, and 1.49 million yuan on January 20, 2026 [4]. - The total net purchase amount from the leaderboard during the 15-day period reached 123 million yuan, indicating a fierce competition for shares [4]. Group 3: Potential Control Disputes - The capital accumulation around Dongtong Tui resembles previous cases, such as Guangyi Tui, where coordinated buying led to significant shareholding increases without proper disclosure [5]. - There are indications that the buying may involve multiple accounts to circumvent regulatory limits on daily purchases, suggesting potential collusion among investors [6][7]. - The weak control structure of Dongtong Tui, with the controlling shareholder's stake being only 7.66%, presents an opportunity for capital intervention and control disputes [9]. Group 4: Financial Health - Despite its delisting due to major violations, Dongtong Tui's financial situation appears relatively stable, with total assets of 3.435 billion yuan and liabilities of only 381 million yuan as of September 30, 2025 [9]. - The company reported a revenue of 419 million yuan in the first three quarters of 2025, with a gross margin of 72.86%, although it still recorded a net loss of 83.99 million yuan [9].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國恒嘉融資租賃集團有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 FF301 III.已發行股份及/或庫存股份變動詳情 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00379 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 4,000,000,000 | HKD | | 0.1 HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 4,000,000,000 | HKD | | ...